Learn Clinical Research Online


One step closer to finding a cure for brain diseases

Credit: Daegu Gyeongbuk Institute of Science and Technology (DGIST) A research team led by Professor Jaewon Ko and Ji Won Um from Department of Brain and Cognitive Sciences identified a new principle of formation of brain synapses through synaptic binding protein complexes. Many nerve cells that make up the brain control the function of the […]

Read More

Tree shrew tolerance for spicy foods unlocked by researchers

Credit: MA Xiaofeng Spicy foods elicit a pungent or hot and painful sensation that repels most mammals. However, the tree shrew (Tupaia belangeri chinensis), a species closely related to primates, seems to violate this rule of thumb. Researchers accidentally observed tree shrews directly and actively consuming chili peppers, despite the deep geographic isolation between the […]

Read More

Synapse-specific plasticity governs the identity of overlapping memory traces

Credit: Kaoru Inokuchi, Kareem Abdou Memories are formed through long-term changes in synaptic efficacy, a process known as synaptic plasticity, and are stored in the brain in specific neuronal ensembles called engram cells, which are activated during corresponding events. When two memories are associated, cell ensembles corresponding to each memory overlap. However, each memory has […]

Read More

Mice study implicates fat as obesity cause

Credit: Pixbay What we eat plays a big role in our ability to regulate our body weight. Over time, however, different ideas have emerged about the most important dietary factors that cause us to put on weight. During the 1980s and 1990s, it was widely accepted that the most important factor in weight gain is […]

Read More

French Biotech Raises €12.5M for Antibiotic Booster Drugs

French-biotech Antabio closed €12.5M at series A to fund its pipeline of antibiotic booster drugs that should help in the global fight against antimicrobial resistance. After raising €7.3M last year, Antabio extended its Series A financing round with €5.2M of additional funding raised from private investors. The French biotech will use the funding to continue […]

Read More

This Spanish Biotech’s Drugs Can Cross the Blood-Brain Barrier

Today, we’re in Barcelona visiting iProteos, a biotech that is developing drugs that can cross the blood-brain barrier to treat a range of neurological disorders and schizophrenia. Mission: iProteos is developing treatments for central nervous system (CNS) disorders, such as Parkinson’s disease and epilepsy, as well as schizophrenia. The Spanish biotech’s drugs mimic the action […]

Read More